| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome, Human | 52 | 2026 | 1323 | 8.230 |
Why?
|
| High-Throughput Nucleotide Sequencing | 50 | 2026 | 916 | 7.830 |
Why?
|
| Genomic Structural Variation | 26 | 2026 | 94 | 7.490 |
Why?
|
| Sequence Analysis, DNA | 53 | 2026 | 1729 | 6.980 |
Why?
|
| Genomics | 44 | 2026 | 1622 | 6.620 |
Why?
|
| Software | 26 | 2026 | 736 | 5.470 |
Why?
|
| Computational Biology | 13 | 2025 | 867 | 2.740 |
Why?
|
| Genetic Variation | 19 | 2025 | 1558 | 2.390 |
Why?
|
| Haplotypes | 14 | 2024 | 522 | 2.200 |
Why?
|
| DNA Methylation | 10 | 2026 | 1093 | 2.150 |
Why?
|
| Polymorphism, Single Nucleotide | 21 | 2026 | 2849 | 1.890 |
Why?
|
| DNA Copy Number Variations | 16 | 2026 | 1028 | 1.690 |
Why?
|
| Sequence Alignment | 5 | 2026 | 585 | 1.520 |
Why?
|
| Benchmarking | 11 | 2025 | 136 | 1.450 |
Why?
|
| Genome | 12 | 2024 | 467 | 1.330 |
Why?
|
| Algorithms | 8 | 2025 | 1677 | 1.210 |
Why?
|
| Alleles | 8 | 2025 | 1671 | 1.190 |
Why?
|
| Genotyping Techniques | 5 | 2025 | 110 | 1.150 |
Why?
|
| Tandem Repeat Sequences | 3 | 2024 | 35 | 1.100 |
Why?
|
| Metagenomics | 3 | 2025 | 115 | 1.050 |
Why?
|
| Nanopores | 8 | 2022 | 8 | 1.030 |
Why?
|
| Germ Cells | 4 | 2026 | 201 | 0.970 |
Why?
|
| Humans | 111 | 2026 | 130776 | 0.960 |
Why?
|
| Mosaicism | 3 | 2025 | 250 | 0.950 |
Why?
|
| Whole Genome Sequencing | 13 | 2026 | 358 | 0.950 |
Why?
|
| Polymorphism, Genetic | 2 | 2023 | 775 | 0.940 |
Why?
|
| Chromosome Mapping | 7 | 2023 | 1053 | 0.890 |
Why?
|
| DNA Transposable Elements | 4 | 2025 | 182 | 0.880 |
Why?
|
| Hominidae | 1 | 2024 | 27 | 0.870 |
Why?
|
| Population Health | 1 | 2024 | 35 | 0.800 |
Why?
|
| Lipoprotein(a) | 1 | 2024 | 140 | 0.780 |
Why?
|
| Transcriptome | 7 | 2026 | 1130 | 0.780 |
Why?
|
| INDEL Mutation | 8 | 2026 | 93 | 0.770 |
Why?
|
| Genotype | 9 | 2025 | 2611 | 0.740 |
Why?
|
| Microbiota | 2 | 2025 | 445 | 0.730 |
Why?
|
| Cryptosporidium | 1 | 2022 | 26 | 0.720 |
Why?
|
| Hybridization, Genetic | 3 | 2019 | 20 | 0.720 |
Why?
|
| Cryptosporidium parvum | 1 | 2022 | 21 | 0.720 |
Why?
|
| Cryptosporidiosis | 1 | 2022 | 34 | 0.710 |
Why?
|
| Industrial Development | 1 | 2021 | 2 | 0.700 |
Why?
|
| Neoplasms | 7 | 2026 | 2956 | 0.700 |
Why?
|
| Gene Rearrangement | 6 | 2026 | 328 | 0.660 |
Why?
|
| Perciformes | 2 | 2017 | 10 | 0.640 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 773 | 0.610 |
Why?
|
| Germ-Line Mutation | 4 | 2026 | 373 | 0.580 |
Why?
|
| DNA Mutational Analysis | 2 | 2019 | 788 | 0.510 |
Why?
|
| Arabidopsis | 4 | 2019 | 91 | 0.510 |
Why?
|
| Molecular Sequence Annotation | 4 | 2025 | 151 | 0.500 |
Why?
|
| Chromosomes, Human, Y | 3 | 2026 | 52 | 0.480 |
Why?
|
| Genome, Viral | 4 | 2025 | 157 | 0.460 |
Why?
|
| Base Sequence | 9 | 2023 | 2746 | 0.460 |
Why?
|
| Genome, Plant | 6 | 2020 | 21 | 0.440 |
Why?
|
| Genome-Wide Association Study | 6 | 2026 | 1840 | 0.420 |
Why?
|
| Metagenome | 2 | 2025 | 142 | 0.410 |
Why?
|
| Genetics, Population | 4 | 2024 | 180 | 0.410 |
Why?
|
| Animals | 24 | 2026 | 33891 | 0.390 |
Why?
|
| Forensic Genetics | 2 | 2026 | 15 | 0.390 |
Why?
|
| Brain | 5 | 2025 | 3222 | 0.370 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 1843 | 0.360 |
Why?
|
| Glucosylceramidase | 3 | 2022 | 35 | 0.360 |
Why?
|
| Gene Frequency | 3 | 2022 | 738 | 0.360 |
Why?
|
| Phenotype | 11 | 2026 | 4479 | 0.350 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 2099 | 0.350 |
Why?
|
| Single-Cell Analysis | 2 | 2025 | 360 | 0.350 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2026 | 3417 | 0.350 |
Why?
|
| Mutation | 7 | 2025 | 6145 | 0.340 |
Why?
|
| Proteome | 2 | 2026 | 287 | 0.330 |
Why?
|
| Parkinson Disease | 3 | 2023 | 723 | 0.330 |
Why?
|
| Diploidy | 3 | 2020 | 40 | 0.330 |
Why?
|
| Machine Learning | 2 | 2024 | 383 | 0.330 |
Why?
|
| DNA, Circular | 2 | 2020 | 17 | 0.320 |
Why?
|
| Abnormalities, Multiple | 3 | 2026 | 973 | 0.310 |
Why?
|
| Chromatin | 2 | 2025 | 501 | 0.300 |
Why?
|
| Exome | 3 | 2023 | 1077 | 0.290 |
Why?
|
| Chromosome Inversion | 3 | 2024 | 72 | 0.290 |
Why?
|
| Chromosomes, Human | 4 | 2022 | 120 | 0.290 |
Why?
|
| DNA Fingerprinting | 2 | 2026 | 108 | 0.280 |
Why?
|
| Genetic Testing | 4 | 2025 | 1086 | 0.280 |
Why?
|
| Schizosaccharomyces | 2 | 2019 | 63 | 0.270 |
Why?
|
| Quantitative Trait Loci | 4 | 2023 | 304 | 0.270 |
Why?
|
| Microsatellite Repeats | 2 | 2026 | 210 | 0.270 |
Why?
|
| Gene Duplication | 4 | 2024 | 361 | 0.260 |
Why?
|
| RNA Editing | 3 | 2025 | 32 | 0.260 |
Why?
|
| Evolution, Molecular | 4 | 2019 | 656 | 0.260 |
Why?
|
| Genome, Fungal | 2 | 2017 | 34 | 0.250 |
Why?
|
| Circadian Clocks | 2 | 2019 | 86 | 0.250 |
Why?
|
| Rare Diseases | 2 | 2025 | 210 | 0.240 |
Why?
|
| Cell Line, Tumor | 5 | 2025 | 3700 | 0.240 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2022 | 620 | 0.240 |
Why?
|
| Human Genome Project | 2 | 2024 | 55 | 0.240 |
Why?
|
| Brain Neoplasms | 2 | 2025 | 1307 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2026 | 121 | 0.230 |
Why?
|
| Epigenomics | 2 | 2025 | 183 | 0.230 |
Why?
|
| Cell Line | 4 | 2024 | 2569 | 0.230 |
Why?
|
| Lymphoma | 2 | 2021 | 331 | 0.230 |
Why?
|
| Epistasis, Genetic | 3 | 2020 | 98 | 0.220 |
Why?
|
| Sequence Analysis | 2 | 2023 | 50 | 0.220 |
Why?
|
| Pitheciidae | 1 | 2024 | 1 | 0.210 |
Why?
|
| Organ Specificity | 1 | 2025 | 397 | 0.210 |
Why?
|
| Major Histocompatibility Complex | 2 | 2023 | 49 | 0.210 |
Why?
|
| DNA | 4 | 2022 | 1413 | 0.210 |
Why?
|
| Genetic Association Studies | 2 | 2026 | 823 | 0.210 |
Why?
|
| Chromosomes, Human, X | 1 | 2025 | 155 | 0.210 |
Why?
|
| Tetralogy of Fallot | 1 | 2026 | 180 | 0.210 |
Why?
|
| Proteomics | 3 | 2026 | 605 | 0.200 |
Why?
|
| Adenosine Deaminase | 2 | 2014 | 89 | 0.200 |
Why?
|
| Breast Neoplasms | 3 | 2020 | 2648 | 0.190 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2025 | 189 | 0.190 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2026 | 2020 | 0.190 |
Why?
|
| Blood Cells | 1 | 2022 | 53 | 0.190 |
Why?
|
| Sequence Analysis, RNA | 1 | 2025 | 418 | 0.190 |
Why?
|
| Gene Expression Regulation, Plant | 2 | 2020 | 63 | 0.190 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2025 | 233 | 0.190 |
Why?
|
| Caliciviridae Infections | 1 | 2025 | 287 | 0.190 |
Why?
|
| Lewy Body Disease | 1 | 2022 | 16 | 0.190 |
Why?
|
| Chromosomes, Mammalian | 1 | 2022 | 40 | 0.180 |
Why?
|
| Mesocricetus | 1 | 2022 | 66 | 0.180 |
Why?
|
| Congenital Abnormalities | 1 | 2026 | 320 | 0.180 |
Why?
|
| Norovirus | 1 | 2025 | 285 | 0.180 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 528 | 0.180 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2024 | 283 | 0.180 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2022 | 68 | 0.180 |
Why?
|
| Phylogeny | 5 | 2025 | 706 | 0.180 |
Why?
|
| Macaca mulatta | 1 | 2023 | 494 | 0.170 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2025 | 385 | 0.170 |
Why?
|
| RNA-Binding Proteins | 4 | 2023 | 545 | 0.170 |
Why?
|
| Bias | 1 | 2021 | 145 | 0.170 |
Why?
|
| Reproductive Isolation | 2 | 2019 | 5 | 0.170 |
Why?
|
| Genomic Instability | 1 | 2022 | 246 | 0.170 |
Why?
|
| Songbirds | 1 | 2020 | 6 | 0.160 |
Why?
|
| Crops, Agricultural | 1 | 2020 | 14 | 0.160 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2022 | 202 | 0.160 |
Why?
|
| Microcephaly | 1 | 2023 | 347 | 0.160 |
Why?
|
| Medical Oncology | 1 | 2021 | 238 | 0.160 |
Why?
|
| Polychondritis, Relapsing | 1 | 2019 | 3 | 0.160 |
Why?
|
| Genome, Mitochondrial | 1 | 2019 | 26 | 0.150 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2023 | 265 | 0.150 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2021 | 236 | 0.150 |
Why?
|
| Workflow | 1 | 2020 | 140 | 0.150 |
Why?
|
| Domestication | 1 | 2019 | 4 | 0.150 |
Why?
|
| Annelida | 1 | 2019 | 1 | 0.150 |
Why?
|
| Fishes | 1 | 2019 | 33 | 0.150 |
Why?
|
| Deafness | 1 | 2019 | 78 | 0.150 |
Why?
|
| Gaucher Disease | 1 | 2019 | 13 | 0.150 |
Why?
|
| Sexual Maturation | 1 | 2019 | 46 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2025 | 743 | 0.150 |
Why?
|
| Arthritis | 1 | 2019 | 83 | 0.150 |
Why?
|
| CpG Islands | 3 | 2026 | 340 | 0.140 |
Why?
|
| Precision Medicine | 1 | 2022 | 381 | 0.140 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 384 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2021 | 495 | 0.140 |
Why?
|
| Gene Amplification | 1 | 2018 | 226 | 0.130 |
Why?
|
| Oncogenes | 1 | 2018 | 164 | 0.130 |
Why?
|
| Introduced Species | 1 | 2017 | 22 | 0.130 |
Why?
|
| Tidal Waves | 1 | 2016 | 1 | 0.130 |
Why?
|
| Chironomidae | 1 | 2016 | 2 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2019 | 364 | 0.130 |
Why?
|
| Heterozygote | 4 | 2022 | 721 | 0.130 |
Why?
|
| Acclimatization | 1 | 2016 | 20 | 0.130 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2017 | 104 | 0.120 |
Why?
|
| Bass | 1 | 2016 | 2 | 0.120 |
Why?
|
| Exons | 1 | 2019 | 761 | 0.120 |
Why?
|
| Genome, Insect | 1 | 2016 | 81 | 0.120 |
Why?
|
| MicroRNAs | 2 | 2014 | 899 | 0.120 |
Why?
|
| Computer Simulation | 1 | 2019 | 680 | 0.120 |
Why?
|
| Critical Care | 1 | 2022 | 683 | 0.120 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 2937 | 0.120 |
Why?
|
| Female | 17 | 2026 | 70630 | 0.120 |
Why?
|
| Ananas | 1 | 2015 | 1 | 0.120 |
Why?
|
| Biological Evolution | 1 | 2017 | 227 | 0.120 |
Why?
|
| Photosynthesis | 1 | 2015 | 12 | 0.120 |
Why?
|
| Male | 15 | 2026 | 64680 | 0.120 |
Why?
|
| Leukemia Virus, Feline | 1 | 2015 | 5 | 0.110 |
Why?
|
| Retroviridae Infections | 1 | 2015 | 10 | 0.110 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2019 | 470 | 0.110 |
Why?
|
| Intellectual Disability | 1 | 2022 | 1077 | 0.110 |
Why?
|
| Cat Diseases | 1 | 2015 | 15 | 0.110 |
Why?
|
| Candida albicans | 1 | 2015 | 87 | 0.110 |
Why?
|
| Reference Standards | 3 | 2023 | 229 | 0.110 |
Why?
|
| Histone Acetyltransferases | 1 | 2015 | 224 | 0.110 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 121 | 0.110 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2015 | 126 | 0.110 |
Why?
|
| Candidiasis | 1 | 2015 | 131 | 0.110 |
Why?
|
| Tumor Virus Infections | 1 | 2015 | 131 | 0.110 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2021 | 950 | 0.110 |
Why?
|
| Mutation, Missense | 1 | 2019 | 934 | 0.100 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 315 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 252 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2015 | 597 | 0.100 |
Why?
|
| Ethyl Methanesulfonate | 1 | 2012 | 7 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 380 | 0.100 |
Why?
|
| Sulfites | 1 | 2012 | 27 | 0.090 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2024 | 73 | 0.090 |
Why?
|
| Nucleotides | 2 | 2022 | 90 | 0.090 |
Why?
|
| Clonal Evolution | 2 | 2023 | 47 | 0.090 |
Why?
|
| Mutagenesis | 1 | 2012 | 331 | 0.090 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2024 | 569 | 0.090 |
Why?
|
| Telomere | 2 | 2023 | 219 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2015 | 803 | 0.080 |
Why?
|
| Mass Spectrometry | 2 | 2026 | 363 | 0.080 |
Why?
|
| Plant Breeding | 2 | 2020 | 8 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 414 | 0.080 |
Why?
|
| Databases, Genetic | 2 | 2024 | 505 | 0.070 |
Why?
|
| MCF-7 Cells | 2 | 2020 | 209 | 0.070 |
Why?
|
| HLA Antigens | 2 | 2021 | 225 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2024 | 1213 | 0.070 |
Why?
|
| Child, Preschool | 4 | 2025 | 15011 | 0.070 |
Why?
|
| Pedigree | 2 | 2023 | 1683 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 989 | 0.070 |
Why?
|
| RNA, Viral | 2 | 2021 | 510 | 0.060 |
Why?
|
| Reproduction | 2 | 2019 | 214 | 0.060 |
Why?
|
| Consanguinity | 1 | 2026 | 119 | 0.060 |
Why?
|
| Oligonucleotide Probes | 1 | 2025 | 85 | 0.060 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2025 | 39 | 0.060 |
Why?
|
| Neanderthals | 1 | 2025 | 1 | 0.060 |
Why?
|
| Adolescent | 4 | 2025 | 20832 | 0.060 |
Why?
|
| Clone Cells | 1 | 2025 | 153 | 0.060 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2024 | 52 | 0.050 |
Why?
|
| Pan troglodytes | 1 | 2024 | 71 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2025 | 419 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2022 | 1950 | 0.050 |
Why?
|
| China | 1 | 2025 | 282 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2024 | 133 | 0.050 |
Why?
|
| Homozygote | 1 | 2026 | 542 | 0.050 |
Why?
|
| Deleted in Azoospermia 1 Protein | 1 | 2023 | 1 | 0.050 |
Why?
|
| DNA, Satellite | 1 | 2023 | 14 | 0.050 |
Why?
|
| Heterochromatin | 1 | 2023 | 54 | 0.050 |
Why?
|
| Segmental Duplications, Genomic | 1 | 2023 | 81 | 0.050 |
Why?
|
| Virus Integration | 1 | 2023 | 37 | 0.050 |
Why?
|
| Methylation | 1 | 2023 | 197 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2023 | 25 | 0.050 |
Why?
|
| Gastroenteritis | 1 | 2025 | 308 | 0.050 |
Why?
|
| Qa-SNARE Proteins | 1 | 2022 | 21 | 0.050 |
Why?
|
| Iran | 1 | 2023 | 97 | 0.050 |
Why?
|
| Multigene Family | 1 | 2023 | 290 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2022 | 42 | 0.050 |
Why?
|
| Models, Animal | 1 | 2024 | 456 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 84 | 0.050 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2022 | 89 | 0.050 |
Why?
|
| Papillomaviridae | 1 | 2023 | 178 | 0.040 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 110 | 0.040 |
Why?
|
| Base Pair Mismatch | 1 | 2021 | 19 | 0.040 |
Why?
|
| Leukemia, B-Cell | 1 | 2021 | 25 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2023 | 204 | 0.040 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2021 | 66 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 249 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2022 | 317 | 0.040 |
Why?
|
| New York City | 1 | 2021 | 62 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2021 | 199 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2021 | 432 | 0.040 |
Why?
|
| Reference Values | 1 | 2022 | 680 | 0.040 |
Why?
|
| RNA | 1 | 2024 | 517 | 0.040 |
Why?
|
| Ecotype | 1 | 2020 | 4 | 0.040 |
Why?
|
| Inbreeding | 1 | 2020 | 7 | 0.040 |
Why?
|
| Transgenes | 1 | 2021 | 320 | 0.040 |
Why?
|
| Haploidy | 1 | 2020 | 17 | 0.040 |
Why?
|
| Mice | 4 | 2025 | 18208 | 0.040 |
Why?
|
| Retroelements | 1 | 2020 | 43 | 0.040 |
Why?
|
| Genome, Bacterial | 1 | 2021 | 208 | 0.040 |
Why?
|
| Child | 3 | 2025 | 26214 | 0.040 |
Why?
|
| Introns | 1 | 2021 | 281 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2021 | 236 | 0.040 |
Why?
|
| Shock, Cardiogenic | 1 | 2022 | 174 | 0.040 |
Why?
|
| Methyltransferases | 1 | 2020 | 77 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2021 | 342 | 0.040 |
Why?
|
| Status Epilepticus | 1 | 2022 | 157 | 0.040 |
Why?
|
| Lymphoma, B-Cell | 1 | 2021 | 148 | 0.040 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2021 | 139 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2021 | 492 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2021 | 170 | 0.040 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2020 | 112 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 284 | 0.040 |
Why?
|
| Viral Load | 1 | 2021 | 402 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 217 | 0.040 |
Why?
|
| Flowers | 1 | 2019 | 9 | 0.040 |
Why?
|
| Plants, Genetically Modified | 1 | 2019 | 39 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2023 | 8567 | 0.040 |
Why?
|
| Chromosome Breakpoints | 1 | 2019 | 82 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2023 | 698 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 1462 | 0.040 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2019 | 51 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 256 | 0.040 |
Why?
|
| Fruit | 1 | 2020 | 235 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2020 | 220 | 0.040 |
Why?
|
| Chromosome Duplication | 1 | 2019 | 147 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 231 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2020 | 356 | 0.030 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2019 | 107 | 0.030 |
Why?
|
| Genome Size | 1 | 2017 | 13 | 0.030 |
Why?
|
| Aging | 1 | 2025 | 1252 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2025 | 834 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2019 | 423 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2018 | 331 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2020 | 766 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2023 | 1218 | 0.030 |
Why?
|
| Organoids | 1 | 2020 | 306 | 0.030 |
Why?
|
| Chromosomes, Fungal | 1 | 2017 | 48 | 0.030 |
Why?
|
| DNA, Plant | 1 | 2016 | 9 | 0.030 |
Why?
|
| Moon | 1 | 2016 | 13 | 0.030 |
Why?
|
| Basidiomycota | 1 | 2016 | 10 | 0.030 |
Why?
|
| CLOCK Proteins | 1 | 2016 | 34 | 0.030 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2017 | 55 | 0.030 |
Why?
|
| DNA Replication | 1 | 2019 | 357 | 0.030 |
Why?
|
| Vitis | 1 | 2016 | 14 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 316 | 0.030 |
Why?
|
| DNA, Fungal | 1 | 2016 | 77 | 0.030 |
Why?
|
| Gene Editing | 1 | 2019 | 230 | 0.030 |
Why?
|
| Gestational Age | 1 | 2020 | 1229 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 317 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2019 | 747 | 0.030 |
Why?
|
| Species Specificity | 1 | 2016 | 490 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2016 | 138 | 0.030 |
Why?
|
| DNA Repair | 1 | 2019 | 580 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 811 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 291 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 229 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2014 | 3831 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 5089 | 0.030 |
Why?
|
| Cats | 1 | 2015 | 119 | 0.030 |
Why?
|
| Virulence | 1 | 2015 | 270 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2017 | 349 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 309 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2014 | 66 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 752 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2905 | 0.030 |
Why?
|
| Internet | 1 | 2017 | 418 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 2126 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 1158 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1692 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2022 | 2440 | 0.020 |
Why?
|
| Aged | 2 | 2021 | 20958 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 1218 | 0.020 |
Why?
|
| Cytosine | 1 | 2012 | 58 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 1457 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 809 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 1382 | 0.020 |
Why?
|
| Middle Aged | 2 | 2022 | 28499 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 850 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 240 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2012 | 206 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2012 | 519 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 1144 | 0.020 |
Why?
|
| Pregnancy | 1 | 2020 | 7499 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3418 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 6241 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 4670 | 0.020 |
Why?
|
| Infant | 1 | 2022 | 13323 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 4695 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2012 | 2558 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 31269 | 0.010 |
Why?
|